These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 6318711

  • 1. Establishment of Epstein-Barr virus (EBV)-associated nuclear antigen (EBNA)-positive nasopharyngeal carcinoma hybrid cell line (NPC-KT).
    Takimoto T, Kamide M, Umeda R.
    Arch Otorhinolaryngol; 1984; 239(1):87-92. PubMed ID: 6318711
    [Abstract] [Full Text] [Related]

  • 2. Establishment of an Epstein-Barr virus (EBV) genome-positive subline of Ramos (Ramos/NPC) following infection of Ramos with nasopharyngeal carcinoma (NPC)-derived EBV.
    Takimoto T, Sato H, Ogura H, Miyazaki T.
    Auris Nasus Larynx; 1987; 14(2):87-92. PubMed ID: 2835030
    [Abstract] [Full Text] [Related]

  • 3. Two epithelial tumor cell lines (HNE-1 and HONE-1) latently infected with Epstein-Barr virus that were derived from nasopharyngeal carcinomas.
    Glaser R, Zhang HY, Yao KT, Zhu HC, Wang FX, Li GY, Wen DS, Li YP.
    Proc Natl Acad Sci U S A; 1989 Dec; 86(23):9524-8. PubMed ID: 2556716
    [Abstract] [Full Text] [Related]

  • 4. Cell fusion by nasopharyngeal carcinoma-derived Epstein-Barr virus.
    Takimoto T, Sato H, Ogura H, Miyazaki T.
    Arch Otolaryngol Head Neck Surg; 1987 May; 113(5):510-3. PubMed ID: 3032215
    [Abstract] [Full Text] [Related]

  • 5. Marmoset lymphoblastoid cells transformed by NPC-KT-derived Epstein-Barr virus which possesses transforming and superinfecting characteristics.
    Takimoto T, Sato H, Ogura H, Ogura T, Ishikawa S, Iwawaki J.
    ORL J Otorhinolaryngol Relat Spec; 1987 May; 49(4):169-74. PubMed ID: 2819802
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines.
    Chen MR, Tsai CH, Wu FF, Kan SH, Yang CS, Chen JY.
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():447-455. PubMed ID: 10073707
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The expression of HLA, Epstein-Barr virus nuclear antigen and the infiltration of T lymphocyte subsets in nasopharyngeal biopsy tissues].
    Chen X, Cai Y, Sun N.
    Zhonghua Er Bi Yan Hou Ke Za Zhi; 1994 Feb; 29(1):6-9. PubMed ID: 8031607
    [Abstract] [Full Text] [Related]

  • 11. Epstein-Barr virus gene expression in nasopharyngeal carcinoma.
    Young LS, Dawson CW, Clark D, Rupani H, Busson P, Tursz T, Johnson A, Rickinson AB.
    J Gen Virol; 1988 May; 69 ( Pt 5)():1051-65. PubMed ID: 2836550
    [Abstract] [Full Text] [Related]

  • 12. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF, Levine PH, Neubauer RH, Rabin H.
    Int J Cancer; 1982 Nov 15; 30(5):581-5. PubMed ID: 6295966
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus nuclear antigen-positive nasopharyngeal hybrid cells.
    Takimoto T, Furukawa M, Hatano M, Umeda R.
    Ann Otol Rhinol Laryngol; 1984 Nov 15; 93(2 Pt 1):166-9. PubMed ID: 6324641
    [Abstract] [Full Text] [Related]

  • 14. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP, Hsu CL, Chang YL, Tsang NM, Chen CK, Lee TJ, Tsao KC, Huang CG, Chang YS, Yu JS, Hao SP.
    Oral Oncol; 2008 Aug 15; 44(8):784-92. PubMed ID: 18206420
    [Abstract] [Full Text] [Related]

  • 15. Evaluation of antibodies to Epstein-Barr virus in Italian patients with nasopharyngeal carcinoma.
    Cevenini R, Donati M, Caliceti U, Moroni A, Tamba I, Rumpianesi F.
    J Infect; 1986 Mar 15; 12(2):127-31. PubMed ID: 3009628
    [Abstract] [Full Text] [Related]

  • 16. Superinfection of epithelial hybrid cells (D98/HR-1, NPC-KT, and A2L/AH) with Epstein-Barr virus and the relationship to the C3d receptor.
    Takimoto T, Sato H, Ogura H, Miyawaki T, Glaser R.
    Cancer Res; 1986 May 15; 46(5):2541-4. PubMed ID: 3008992
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus in somatic cell hybrids between mouse cells and human nasopharyngeal carcinoma cells.
    Steplewski Z, Koprowski H, Andersson-Anvret M, Klein G.
    J Cell Physiol; 1978 Oct 15; 97(1):1-8. PubMed ID: 213442
    [Abstract] [Full Text] [Related]

  • 18. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
    Kurstak E, de Thé G, van den Hurk J, Charpentier G, Kurstak C, Tijssen P, Morisset R.
    J Med Virol; 1978 Oct 15; 2(3):189-200. PubMed ID: 212523
    [Abstract] [Full Text] [Related]

  • 19. [Experimental studies on viral etiology of Epstein-Barr (EBV) in nasopharyngeal carcinoma (NPC):establishment of EBV infection on human epithelial derived from nasopharyngeal tissue (author's transl)].
    Takimoto T.
    Nihon Jibiinkoka Gakkai Kaiho; 1979 Feb 20; 82(2):119-35. PubMed ID: 220401
    [No Abstract] [Full Text] [Related]

  • 20. [Investigation of EB virus DNA BamHI W fragment, EBNA-2 types and EBNA expression in benign and malignant nasopharyngeal biopsies].
    Chen XY, Ning S, Arrand JR.
    Zhonghua Bing Li Xue Za Zhi; 1994 Aug 20; 23(4):200-3. PubMed ID: 7805145
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.